Transcatheter aortic valve replacement (TAVR) use is gaining momentum as the mainstay for the treatment of aortic stenosis compared to surgical aortic valve replacement (SAVR). Unfortunately, TAVR-related infective endocarditis (TAVR-IE) is expected to be detected more and more as a result of the ever-expanding indications in younger patients. Given the overall poor prognosis of TAVR-IE, it is imperative that clinicians familiarize themselves with common presentations, major risk factors, diagnostic pitfalls, therapeutic approaches, and the prevention of TAVR-IE. Herein, we review all of the above in detail with the most updated available literature.
Endocarditis after Transcatheter Aortic Valve Replacement
Lorenzo Braghieri,Simrat Kaur,C. K. Black,Paul C. Cremer,Shinya Unai,S. Kapadia,Amgad Mentias
Published 2023 in Journal of Clinical Medicine
ABSTRACT
PUBLICATION RECORD
- Publication year
2023
- Venue
Journal of Clinical Medicine
- Publication date
2023-11-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-61 of 61 references · Page 1 of 1
CITED BY
Showing 1-6 of 6 citing papers · Page 1 of 1